Log in
(Ad)
What if you could buy one tiny stock today for $10 - at the center of a growing tech industry - that experts believe will explode a massive 77,400%?

Wall Street legend Paul Mampilly recently identified this as the stock of the century.

Buying up a handful of shares of this small company now could change your life and even make you millions.

NYSE:PBH - Prestige Consumer Healthcare Stock Price, Forecast & News

$42.20
+0.31 (+0.74 %)
(As of 01/19/2020 04:00 PM ET)
Today's Range
$41.86
Now: $42.20
$42.50
50-Day Range
$37.52
MA: $39.52
$42.20
52-Week Range
$26.49
Now: $42.20
$42.50
Volume260,800 shs
Average Volume320,506 shs
Market Capitalization$2.12 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.93
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPersonal Products
SectorConsumer Discretionary
CUSIP74112D10
Phone914-524-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$975.78 million
Cash Flow$3.57 per share
Book Value$21.16 per share

Profitability

Net Income$-35,800,000.00

Miscellaneous

Employees530
Market Cap$2.12 billion
Next Earnings Date2/6/2020 (Confirmed)
OptionableOptionable

Receive PBH News and Ratings via Email

Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


Want to know which stocks should be on your radar this week? Every Sunday we send out the 3 Stock Trades that we predict will be big winners for the week ahead.

Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc (NYSE:PBH) announced its quarterly earnings data on Thursday, October, 31st. The company reported $0.68 earnings per share for the quarter, beating analysts' consensus estimates of $0.66 by $0.02. The company earned $238.07 million during the quarter, compared to analyst estimates of $237.17 million. Prestige Consumer Healthcare had a negative net margin of 3.56% and a positive return on equity of 12.68%. The firm's revenue for the quarter was down .5% on a year-over-year basis. During the same quarter last year, the business posted $0.65 EPS. View Prestige Consumer Healthcare's Earnings History.

When is Prestige Consumer Healthcare's next earnings date?

Prestige Consumer Healthcare is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Prestige Consumer Healthcare.

How can I listen to Prestige Consumer Healthcare's earnings call?

Prestige Consumer Healthcare will be holding an earnings conference call on Thursday, February 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare updated its FY20 earnings guidance on Thursday, October, 31st. The company provided EPS guidance of $2.76-2.83 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.82. The company issued revenue guidance of $947-957 million, compared to the consensus revenue estimate of $953.18 million.

What price target have analysts set for PBH?

3 brokerages have issued 12-month price objectives for Prestige Consumer Healthcare's stock. Their forecasts range from $84.00 to $97.00. On average, they expect Prestige Consumer Healthcare's stock price to reach $89.67 in the next twelve months. This suggests a possible upside of 112.5% from the stock's current price. View Analyst Price Targets for Prestige Consumer Healthcare.

What is the consensus analysts' recommendation for Prestige Consumer Healthcare?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Prestige Consumer Healthcare.

Has Prestige Consumer Healthcare been receiving favorable news coverage?

News articles about PBH stock have been trending somewhat positive recently, InfoTrie reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Prestige Consumer Healthcare earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Prestige Consumer Healthcare.

Who are some of Prestige Consumer Healthcare's key competitors?

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Gilead Sciences (GILD), GW Pharmaceuticals PLC- (GWPH), Cara Therapeutics (CARA), IQIYI (IQ), Rigel Pharmaceuticals (RIGL), AbbVie (ABBV), Boeing (BA), Edwards Lifesciences (EW), Johnson & Johnson (JNJ) and AT&T (T).

Who are Prestige Consumer Healthcare's key executives?

Prestige Consumer Healthcare's management team includes the folowing people:
  • Mr. Ronald M. Lombardi, Chairman, Pres & CEO (Age 55)
  • Ms. Christine Sacco, Chief Financial Officer (Age 43)
  • Mr. William C. P'Pool, Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Mr. Timothy J. Connors, Exec. VP of Sales & Marketing (Age 52)
  • Mr. Jeff Zerillo, Sr. VP of Operations

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by a number of of retail and institutional investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (0.69%), Wedge Capital Management L L P NC (0.43%), Skyline Asset Management LP (0.37%), Peregrine Capital Management LLC (0.37%), Nisa Investment Advisors LLC (0.05%) and OLD National Bancorp IN (0.02%). Company insiders that own Prestige Consumer Healthcare stock include Gary E Costley, Jean A Boyko, Natale S Ricciardi, Paton Brett, Ronald M Lombardi, Timothy Connors and William P'pool. View Institutional Ownership Trends for Prestige Consumer Healthcare.

Which major investors are selling Prestige Consumer Healthcare stock?

PBH stock was sold by a variety of institutional investors in the last quarter, including Skyline Asset Management LP, Dalton Greiner Hartman Maher & Co. and State of Alaska Department of Revenue. View Insider Buying and Selling for Prestige Consumer Healthcare.

Which major investors are buying Prestige Consumer Healthcare stock?

PBH stock was bought by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Peregrine Capital Management LLC, Diversified Trust Co, OLD National Bancorp IN and Nisa Investment Advisors LLC. Company insiders that have bought Prestige Consumer Healthcare stock in the last two years include Gary E Costley, Natale S Ricciardi, Ronald M Lombardi and William P'pool. View Insider Buying and Selling for Prestige Consumer Healthcare.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $42.20.

How big of a company is Prestige Consumer Healthcare?

Prestige Consumer Healthcare has a market capitalization of $2.12 billion and generates $975.78 million in revenue each year. The company earns $-35,800,000.00 in net income (profit) each year or $2.78 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe.View Additional Information About Prestige Consumer Healthcare.

What is Prestige Consumer Healthcare's official website?

The official website for Prestige Consumer Healthcare is http://www.prestigebrands.com/.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]


MarketBeat Community Rating for Prestige Consumer Healthcare (NYSE PBH)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  436 (Vote Outperform)
Underperform Votes:  327 (Vote Underperform)
Total Votes:  763
MarketBeat's community ratings are surveys of what our community members think about Prestige Consumer Healthcare and other stocks. Vote "Outperform" if you believe PBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2020 by MarketBeat.com Staff

Featured Article: What is a capital gain?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel